Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$103.66
+0.5%
$103.38
$71.88
$107.53
$153.33B0.687.65 million shs4.12 million shs
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$141.82
-0.4%
$141.28
$103.79
$155.46
$131.37B1.0239,390 shs10,233 shs
Lonza Group Ag stock logo
LZAGY
Lonza Group
$70.57
-1.1%
$69.46
$55.57
$73.29
$49.56B1.1688,626 shs14,349 shs
Stryker Corporation stock logo
SYK
Stryker
$387.31
-0.9%
$385.38
$314.93
$406.19
$147.92B0.911.45 million shs375,974 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
-0.30%+0.15%+1.60%+8.45%+31.96%
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
+1.14%-4.43%+1.81%+1.24%+30.88%
Lonza Group Ag stock logo
LZAGY
Lonza Group
+1.75%+0.55%+2.90%+9.33%+23.58%
Stryker Corporation stock logo
SYK
Stryker
-0.04%-0.36%+3.61%+12.75%+17.16%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Boston Scientific Corporation stock logo
BSX
Boston Scientific
4.6302 of 5 stars
3.63.00.04.23.32.51.3
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
1.8812 of 5 stars
0.05.01.70.02.10.01.3
Lonza Group Ag stock logo
LZAGY
Lonza Group
1.7934 of 5 stars
0.05.00.80.01.50.01.9
Stryker Corporation stock logo
SYK
Stryker
4.4553 of 5 stars
2.42.03.34.23.02.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Boston Scientific Corporation stock logo
BSX
Boston Scientific
3.13
Buy$116.0911.99% Upside
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
2.00
HoldN/AN/A
Lonza Group Ag stock logo
LZAGY
Lonza Group
4.00
Strong BuyN/AN/A
Stryker Corporation stock logo
SYK
Stryker
2.79
Moderate Buy$428.5510.65% Upside

Current Analyst Ratings Breakdown

Latest LZAGY, BSX, SYK, and ESLOY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/14/2025
Stryker Corporation stock logo
SYK
Stryker
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
7/8/2025
Stryker Corporation stock logo
SYK
Stryker
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$390.00 ➝ $415.00
6/16/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/16/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$118.00
5/28/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$115.00
5/22/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$119.00 ➝ $125.00
5/22/2025
Stryker Corporation stock logo
SYK
Stryker
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$443.00 ➝ $455.00
5/16/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$120.00 ➝ $125.00
5/8/2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/5/2025
Stryker Corporation stock logo
SYK
Stryker
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$450.00
5/5/2025
Stryker Corporation stock logo
SYK
Stryker
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$390.00 ➝ $400.00
(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$16.75B9.16$3.66 per share28.35$14.93 per share6.94
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$28.69B4.58$7.43 per share19.10$48.49 per share2.92
Lonza Group Ag stock logo
LZAGY
Lonza Group
$7.47B6.64$2.02 per share34.99$14.76 per share4.78
Stryker Corporation stock logo
SYK
Stryker
$22.60B6.54$14.95 per share25.90$54.13 per share7.16
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$1.85B$1.3775.6532.092.6911.58%18.67%10.38%7/23/2025 (Estimated)
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$2.55BN/A0.0031.594.35N/AN/AN/A7/28/2025 (Estimated)
Lonza Group Ag stock logo
LZAGY
Lonza Group
$722.43MN/A0.0032.522.34N/AN/AN/A7/23/2025 (Estimated)
Stryker Corporation stock logo
SYK
Stryker
$2.99B$7.4052.3726.122.9512.31%23.74%11.25%7/31/2025 (Estimated)

Latest LZAGY, BSX, SYK, and ESLOY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/31/2025Q2 2025
Stryker Corporation stock logo
SYK
Stryker
$3.06N/AN/AN/A$5.92 billionN/A
7/23/2025Q2 2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.72N/AN/AN/A$4.89 billionN/A
5/1/2025Q1 2025
Stryker Corporation stock logo
SYK
Stryker
$2.73$2.84+$0.11$1.69$5.68 billion$5.87 billion
4/23/2025Q1 2025
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.67$0.75+$0.08$0.45$4.57 billion$4.66 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$1.621.14%N/AN/AN/A
Lonza Group Ag stock logo
LZAGY
Lonza Group
$0.110.16%N/AN/AN/A
Stryker Corporation stock logo
SYK
Stryker
$3.360.87%N/A45.41%32 Years

Latest LZAGY, BSX, SYK, and ESLOY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/8/2025
Stryker Corporation stock logo
SYK
Stryker
quarterly$0.840.88%6/30/20256/30/20257/31/2025
5/6/2025
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
$1.83301.26%5/12/20255/13/20256/26/2025
5/10/2025
Lonza Group Ag stock logo
LZAGY
Lonza Group
$0.10540.15%5/14/20255/15/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.47
1.45
0.88
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
0.17
0.95
0.65
Lonza Group Ag stock logo
LZAGY
Lonza Group
0.45
1.52
1.04
Stryker Corporation stock logo
SYK
Stryker
0.69
1.64
1.00

Institutional Ownership

CompanyInstitutional Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
0.01%
Lonza Group Ag stock logo
LZAGY
Lonza Group
0.04%
Stryker Corporation stock logo
SYK
Stryker
77.09%

Insider Ownership

CompanyInsider Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.50%
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
N/A
Lonza Group Ag stock logo
LZAGY
Lonza Group
0.07%
Stryker Corporation stock logo
SYK
Stryker
5.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
53,0001.48 billion1.47 billionOptionable
EssilorLuxottica Unsponsored ADR stock logo
ESLOY
EssilorLuxottica
196,754926.29 millionN/ANot Optionable
Lonza Group Ag stock logo
LZAGY
Lonza Group
18,000702.29 million701.80 millionNot Optionable
Stryker Corporation stock logo
SYK
Stryker
53,000381.69 million359.17 millionOptionable

Recent News About These Companies

10 Best Health Care Stocks to Buy for 2025

New MarketBeat Followers Over Time

Media Sentiment Over Time

Boston Scientific stock logo

Boston Scientific NYSE:BSX

$103.66 +0.47 (+0.45%)
As of 01:20 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

EssilorLuxottica stock logo

EssilorLuxottica OTCMKTS:ESLOY

$141.82 -0.59 (-0.41%)
As of 12:26 PM Eastern

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

Lonza Group stock logo

Lonza Group OTCMKTS:LZAGY

$70.57 -0.76 (-1.07%)
As of 12:48 PM Eastern

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.

Stryker stock logo

Stryker NYSE:SYK

$387.31 -3.56 (-0.91%)
As of 01:20 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.